Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

13.6K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain Tumor Classification and Segmentation in MR Images Using EfficientNet and U-Net++ Models.

Diagnostics (Basel, Switzerland)·2026
Same author

Hybrid Gene Selection Algorithm for Cancer Classification Using Nuclear Reaction Optimization (NRO).

Current issues in molecular biology·2025
Same author

GNR: Genetic-Embedded Nuclear Reaction Optimization with F-Score Filter for Gene Selection in Cancer Classification.

International journal of molecular sciences·2025
Same author

Improving Alzheimer's Disease Prediction with Different Machine Learning Approaches and Feature Selection Techniques.

Diagnostics (Basel, Switzerland)·2024
Same journal

Correction: Luca et al. Global and Regional Diagnostic Results of Progress Toward Cervical Cancer Elimination, According to the WHO Strategy: A Systematic Literature Review with Narrative Synthesis. <i>Diagnostics</i> 2026, <i>16</i>, 1224.

Diagnostics (Basel, Switzerland)·2026
Same journal

Association Between Systemic Inflammatory Response Biomarkers and Disease Activity in Systemic Lupus Erythematosus: A Multi-Center Retrospective Study.

Diagnostics (Basel, Switzerland)·2026
Same journal

Vertebrogenic Low Back Pain and Basivertebral Nerve Ablation: A Review of Mechanisms, Imaging-Driven Selection, and Clinical Outcomes.

Diagnostics (Basel, Switzerland)·2026
Same journal

Multivalvular Carcinoid Heart Disease: The Role of Echocardiography in Diagnosis and Selection for Heterotopic Bicaval Valve Implantation.

Diagnostics (Basel, Switzerland)·2026
Same journal

Data-Efficient and Explainable Multimodal Survival Prediction in NSCLC Using Deep Image Embeddings, Clinical Variables, and Gradient-Boosted Trees.

Diagnostics (Basel, Switzerland)·2026
Same journal

Anomalous Left Coronary Artery from the Pulmonary Artery: Cinematic Volume Rendering Technique for Enhanced Anatomic Visualization.

Diagnostics (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: May 14, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K

Evaluating the Nuclear Reaction Optimization (NRO) Algorithm for Gene Selection in Cancer Classification.

Shahad Alkamli1, Hala Alshamlan1

  • 1Department of Information Technology, College of Computer and Information Sciences, King Saud University, P.O. Box 51178, Riyadh 11543, Saudi Arabia.

Diagnostics (Basel, Switzerland)
|April 12, 2025
PubMed
Summary
This summary is machine-generated.

Nuclear Reaction Optimization (NRO) effectively selects informative genes from high-dimensional cancer microarray data. This method shows promise for cancer classification, though gene subset size can be high without further reduction.

Keywords:
bioinformaticscancer classificationgene selectionmicroarray datanuclear reaction optimization (NRO)optimization algorithms

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

7.8K

Related Experiment Videos

Last Updated: May 14, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

7.8K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Cancer classification from microarray data is challenging due to high dimensionality.
  • Effective gene selection is crucial for accurate cancer subtyping and analysis.
  • Advanced optimization techniques are needed to handle complex genomic datasets.

Purpose of the Study:

  • To introduce and evaluate Nuclear Reaction Optimization (NRO) for gene selection in cancer microarray datasets.
  • To assess NRO's performance as a standalone method without prior dimensionality reduction.
  • To compare NRO's effectiveness against other optimization algorithms for cancer classification.

Main Methods:

  • Nuclear Reaction Optimization (NRO), inspired by nuclear processes, was applied to six cancer microarray datasets.
  • Support Vector Machine (SVM) and k-Nearest Neighbors (k-NN) classifiers were used to evaluate selected gene subsets.
  • Leave-One-Out Cross-Validation (LOOCV) was employed for robust classification accuracy assessment.

Main Results:

  • NRO demonstrated high classification accuracy, especially when combined with SVM.
  • The algorithm showed competitive performance against state-of-the-art methods like HHO, ABC, PSO, and FFA on select datasets.
  • The number of selected genes was relatively high due to the lack of additional feature reduction steps.

Conclusions:

  • Nuclear Reaction Optimization (NRO) is a viable approach for gene selection in cancer classification.
  • Further enhancements can be achieved by integrating NRO with hybrid models and feature reduction techniques.
  • Future research should focus on optimizing gene subset size for improved efficiency and accuracy.